1081MO Phase I study of WNT974 in combination with spartalizumab in patients with cutaneous melanomaP.A. Ascierto, Ana Arance, Jordi Rodon et al.|Annals of Oncology|2024Cited by 3
Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma.Chung‐Han Lee, A. Ari Hakimi, Maria I. Carlo et al.|Journal of Clinical Oncology|2019Cited by 1
MP25-10 GENOMIC BIOMARKERS OF RESPONSE TO NIVOLUMAB/IPILIMUMAB AND NIVOLUMAB MONOTHERAPY IN 108 PATIENTS WITH METASTATIC RENAL CELL CARCINOMARenzo G. DiNatale, A. Ari Hakimi, Chung‐Han Lee et al.|The Journal of Urology|2019Cited by 0